Results 101 to 110 of about 78,942 (265)

Effects of catechins, resveratrol, silymarin components and some of their conjugates on xanthine oxidase‐catalyzed xanthine and 6‐mercaptopurine oxidation

open access: yesJournal of the Science of Food and Agriculture, Volume 105, Issue 5, Page 2765-2776, 30 March 2025.
Abstract BACKGROUND Over the past two decades, the global incidence of gout has markedly increased, affecting people worldwide. Considering the side effects of xanthine oxidase (XO) inhibitor drugs (e.g. allopurinol and febuxostat) used in the treatment of hyperuricemia and gout, the potential application of phytochemicals has been widely studied.
Tímea Bencsik   +6 more
wiley   +1 more source

Longest survivor of pulmonary atresia with ventricular septal defect without surgical intervention

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1499-1507, April 2025.
Sang Zhou   +5 more
wiley   +1 more source

High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame? [PDF]

open access: gold, 2020
Fernando Pérez-Ruiz   +3 more
openalex   +1 more source

A new prediction diagnosis model of incomplete Kawasaki disease based on data mining with big data

open access: yesPediatric Discovery, EarlyView.
In this study, based on a medical big data information mining approach, we mined the independent risk factors for incomplete Kawasaki disease prediction by comparing incomplete Kawasaki disease with related febrile illnesses and constructed an auxiliary diagnostic model used to predict incomplete Kawasaki disease.
Zhen Yang   +4 more
wiley   +1 more source

Research progress in the application of single‐cell sequencing technology in rheumatic diseases

open access: yesRheumatology &Autoimmunity, EarlyView.
Application of single‐cell RNA sequencing (scRNA‐seq) technology in the study of the pathogenesis of rheumatic diseases. Tree of content illustration depicting the multi‐layered insights from scRNA‐seq in rheumatic diseases. The outer layer highlights key cell subsets identified by scRNA‐seq in rheumatoid arthritis, systemic lupus erythematosus ...
Xinzhe Feng   +5 more
wiley   +1 more source

Long‐term remission in gout: Challenges and future opportunities

open access: yesRheumatology &Autoimmunity, EarlyView.
Prolonged hyperuricemia is a major risk factor for gout, which is now regarded as a curable disease. Awareness of the various factors that can trigger gout flares is essential for their prevention. An important determinant of treatment decisions and long‐term follow‐up is the quality of the clinician–patient relationship. The “treat‐to‐target” approach
Patapong Towiwat, Zhanguo Li
wiley   +1 more source

Assessing the Causal Effects of Adipokines on Uric Acid and Gout: A Two-Sample Mendelian Randomization Study [PDF]

open access: gold, 2022
Ruyi Cong   +10 more
openalex   +1 more source

Expert consensus on early diagnosis and treatment of psoriatic arthritis (2025 edition)

open access: yesRheumatology &Autoimmunity, EarlyView.
Psoriatic arthritis (PsA) is a chronic inflammatory musculoskeletal disease associated with psoriasis. PsA is characterized by diverse clinical manifestations and often follows a protracted, relapsing course, potentially leading to joint deformity and disability.
Ranran Yao   +7 more
wiley   +1 more source

Gout Flare Burden in the United States: A Multiyear Cross‐Sectional Survey Study

open access: yesACR Open Rheumatology
Objective The objective of this study was to assess the burden of gout flares and examine associated patient characteristics and outcomes in a sample of US adults.
Jasvinder A. Singh   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy